|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 471/04 | (2006.01) |
| C07D 471/04 | (2013.01) |
| (11) | Patento numeris | 3915984 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 20740931.9 |
| Europos patento paraiškos padavimo data | 2020-01-17 | |
| (97) | Europos patento paraiškos paskelbimo data | 2021-12-01 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2024-10-30 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/CN2020/072582 |
| Data | 2020-01-17 |
| (87) | Numeris | WO 2020/147803 |
| Data | 2020-07-23 |
| (30) | Numeris | Data | Šalis |
| 201910057056 | 2019-01-19 | CN | |
| 202010037085 | 2020-01-14 | CN |
| (72) |
SHI, Dongfang , CN
FU, Changjin , CN
GU, Jie , CN
ZHANG, Min , CN
GONG, Weiwei , CN
LI, Pengfei , CN
|
| (73) |
Jiangsu Atom Bioscience and
Pharmaceutical Co., Ltd. ,
Suite 401, Building C31, Biomedical Industry Park
218 Xinghu Street, Suzhou Industrial Park
China (Jiangsu) Pilot Free Trade Zone-Suzhou Area, Suzhou City, Jiangsu Province, 215123,
CN
|
| (54) | SYNTHESIS OF 3-BROMO-5-(2-ETHYLIMIDAZO[1,2-ALPHA]PYRIDINE-3-CARBONYL)-2-HYDROXYBENZONITRILE |
| SYNTHESIS OF 3-BROMO-5-(2-ETHYLIMIDAZO[1,2-ALPHA]PYRIDINE-3-CARBONYL)-2-HYDROXYBENZONITRILE |